Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/EJE-07-0757
European Journal of Endocrinology, Vol 158, Issue 5, 661-668
Copyright © 2008 by Society of the European Journal of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by McGuigan, F.
Right arrow Articles by Åkesson, K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGuigan, F.
Right arrow Articles by Åkesson, K.

CLINICAL STUDIES

Variation in the bone morphogenetic protein-2 gene: effects on fat and lean body mass in young and elderly women

Fiona McGuigan1,2, Emma Larzenius1,2, Mattias Callreus1,2, Paul Gerdhem1,3, Holger Luthman4 and Kristina Åkesson1,2

1 Clinical and Molecular Osteoporosis Research Unit, Department of Clinical Sciences Malmö, Lund University, 205 02 Malmö, Sweden2 Department of Orthopaedics, Malmö University Hospital, 205 02 Malmö, Sweden3 Department of Orthopaedics, Karolinska University Hospital, S-171 76 Stockholm, Sweden4 Medical Genetics Unit, Department of Clinical Sciences Malmö, Lund University, 205 20 Malmö, Sweden

(Correspondence should be addressed to K Åkesson; Email: kristina.akesson{at}med.lu.se)

Objective: Bone morphogenetic protein-2 (BMP2) plays a critical role in osteoblastogenesis and adipogenesis from osteoprogenitor cells. The balance between osteogenic and adipogenic effects is influenced by BMP2 concentration, transcription factors and age. BMP2 single nucleotide polymorphisms (SNPs) may contribute to osteoporosis risk, but the relationship between adiposity and body composition has not been explored. We investigated the relationship between BMP2 polymorphisms and body composition in young and elderly women.

Design: Population-based association study.

Methods: Four BMP2 SNPs studied. Total body fat and lean mass measured by DEXA in two cohorts: ‘PEAK-25’ women aged 25 (±0.00) (n=993) and osteoporosis prospective risk assessment (OPRA) women aged 75 (±0.00) years (n=1001).

Results: We found no association between BMP2 SNPs and fat or lean mass, however, we observed consistent although non-significant trends. Polymorphisms, rs235767 and Ser37Ala, exerted opposing effects on most parameters of soft tissue and bone mass in both cohorts. This relationship appeared to be age specific with large differences between alleles observed (fat mass; Ser37Ala: 14.3% (PEAK-25), –3.5% (OPRA)). These initial results appear to suggest that alleles exerting a beneficial effect in young women may subsequently contribute to phenotypes associated with osteoporosis risk in elderly women.

Conclusions: While further analyses in other comparative populations are necessary, in this study of almost 2000 women we observed interesting, although non-significant trends, regarding the effects of variation in the BMP2 gene on parameters of body mass. Although the exact nature of the relationship remains uncertain, we suggest that the mechanisms are influenced by age and environmental factors.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society of the European Journal of Endocrinology.